MeiraGTx
- Biotech or pharma, therapeutic R&D
MeiraGTx is a world leading genetics medicines company with 4 pivotal stage programs in Parkinson's disease, Xerostomia (dry mouth), and ophthalmology gene therapy.
The company is also pioneering a first of its kind riboswitch technology, which allows precise control of gene expression with oral small molecule inducers. The company's riboswitch pipeline includes programs in metabolic disease and obesity, cell therapy, gene editing and more.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}